Should I Buy ALL? ALL 2026 Analysis

Should You Buy Allstate Corp (ALL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

207.550

1 Day change

-3.55%

52 Week Range

216.750

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient trader: price ($203) is pressing into near-term resistance (R1 ~202.41, R2 ~205.48) after a run-up, with RSI(6) ~69.5 (near overbought).
Trend is mixed: MACD momentum is improving, but the moving-average stack remains bearish (SMA200 > SMA20 > SMA5), which often caps upside follow-through.
A major event catalyst is imminent: QDEC 2025 earnings after-hours on 2026-02-04—this binary setup is unfavorable if you want immediate, more predictable entry.
Intellectia Proprietary Trading Signals
- AI Stock Picker: No signal on given stock today.
- SwingMax: No signal on given stock recently.

Technical Analysis

Price/levels: Trading around $203, just above R1 (202.414) and below R2 (205.484); support at Pivot (197.444) then S1 (192.474).
Momentum: MACD histogram +0.776 and expanding (bullish momentum pickup).
RSI: RSI_6 at 69.544 (near-overbought/late-stage in the short-term move; upside can be limited without consolidation).
Trend structure: Bearish moving-average alignment (SMA_200 > SMA_20 > SMA_5) suggests the broader trend is still not cleanly bullish.
Pattern-stat edge (provided): modest upside bias, but not strong (next day +1.48% with 40% chance; next week ~flat).

Options Data

Neutral

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning/sentiment: OI put/call ~0.97 (fairly balanced; not strongly bullish or bearish).
Flow: Volume put/call ~0.8 (slightly more calls than puts on volume; mild bullish tilt).
Volatility: 30D IV ~22.83 vs HV ~23.95 (IV not elevated); IV percentile ~30.9 and IV rank ~5.0 (options pricing not signaling a big fear premium).
Activity: Today’s options volume (369) is well below 5D/10D averages (~~964/~~923), implying limited “fresh” conviction in options flow.

Technical Summary

Sell

Buy

Positive Catalysts

- Earnings catalyst: QDEC 2025 earnings after-hours 2026-02-04 could validate profitability momentum and capital return narrative.
- Prior quarter fundamentals were strong (Q3 2025: large YoY EPS and net income rebound), supporting the bull case if durability persists.
- Some supportive Street voices remain (e.g., BofA Buy with high PT; multiple Outperform/Buy ratings still active).

Neutral/Negative Catalysts

- Technical setup is not an attractive chase entry: price is at/near resistance with near-overbought short-term RSI.
- Broader trend signal is still conflicted (bearish MA stack) despite positive MACD.
- Industry backdrop: multiple analysts highlight P&C cycle “softening”/pricing deceleration and tougher 2026 conditions, which can pressure forward estimates.
- Event risk: earnings after-hours creates a binary gap risk that’s unfavorable for an impatient “buy-now” approach.

Financial Performance

Latest quarter provided: 2025/Q3.
Revenue: $17.255B, +3.78% YoY (steady top-line growth).
Net income: $3.717B, +220.16% YoY (major profitability rebound).
EPS: 13.95, +222.17% YoY (sharp earnings acceleration).
Interpretation: Growth is modest on revenue, but margin/profitability improved dramatically versus prior year, consistent with a recovery phase in underwriting results.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: price targets have been mixed but show some trimming into early Jan 2026 (e.g., Evercore cut to $225; Goldman cut to $227) alongside caution about a more challenging/softening P&C cycle.
Offsetting positives: some firms still raised targets or stayed constructive (KBW raised to $254 Outperform; BofA raised to $313 Buy; Roth $240 Buy).
Notable cautions/downgrades: William Blair downgraded to Market Perform; Morgan Stanley downgraded to Equal Weight with PT $215—both citing a more challenging year ahead and that much of the turnaround may be priced in.
Wall Street pros vs cons summary: Pros = strong recent profitability rebound and continued Buy/Outperform coverage; Cons = increasing caution on 2026 cycle/pricing and multiple target cuts/downgrades suggesting more limited near-term upside from here.

18 Analyst Rating

Wall Street analysts forecast ALL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALL is 238.35 USD with a low forecast of 201 USD and a high forecast of 313 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

10 Buy

7 Hold

1 Sell

Moderate Buy

Current: 215.190

Low

201

Averages

238.35

High

313

Current: 215.190

Low

201

Averages

238.35

High

313

Wells Fargo

Elyse Greenspan

Equal Weight

maintain

$223 -> $228

AI Analysis

2026-02-06

New

Reason

Wells Fargo

Elyse Greenspan

Price Target

$223 -> $228

AI Analysis

2026-02-06

New

maintain

Equal Weight

Reason

Wells Fargo analyst Elyse Greenspan raised the firm's price target on Allstate to $228 from $223 and keeps an Equal Weight rating on the shares. The firm says it was surprised Allstate moved as much as it did post EPS, but Wells attributes it to positioning plus P&C stocks outperforming of late.

Goldman Sachs

Buy

maintain

$227 -> $238

2026-02-06

New

Reason

Goldman Sachs

Price Target

$227 -> $238

2026-02-06

New

maintain

Buy

Reason

Goldman Sachs raised the firm's price target on Allstate to $238 from $227 and keeps a Buy rating on the shares. The company remains attractively positioned amongst its insurers peer group, as the firm believes that it can deliver above-historical levels of unit growth and generate above-average returns on top of a strong current capital position, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ALL

Unlock Now

ALL Should I Buy

ALL Should I Buy

Should You Buy Allstate Corp (ALL) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch